Glenmark Pharma gets ANDA approval for Deferasirox Tablets for Oral Suspension – Central Chronicle – Central India s Premier English Daily centralchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from centralchronicle.com Daily Mail and Mail on Sunday newspapers.
Glenmark Pharmaceuticals Inc., USA has received a 2nd tentative approval by the USFDA for Saxagliptin Tablets, 2.5 mg and 5 mg, the generic version of Onglyza® Tablets, 2.5 mg and 5 mg, of AstraZeneca AB.
Glenmark Pharmaceuticals Inc., USA has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials, the generic version of Bumex® Injection.
Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals Limited have reached a settlement agreement with Pfizer Inc., PF Prism C.V., and PF Prism IMB B.V. for Axitinib Tablets, 1 mg and 5 mg, the generic version of their Inlyta® Tablets, 1 mg and